Biochemistry
-
Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate
This article has 16 authors:Reviewed by ScreenIT
-
SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins
This article has 6 authors:Reviewed by ScreenIT
-
A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infection
This article has 19 authors:Reviewed by ScreenIT
-
The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor
This article has 3 authors:Reviewed by ScreenIT
-
Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cells
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
This article has 36 authors:Reviewed by ScreenIT
-
Closing coronavirus spike glycoproteins by structure-guided design
This article has 4 authors:Reviewed by ScreenIT
-
Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays
This article has 13 authors:Reviewed by ScreenIT
-
SARS-CoV-2 envelope protein topology in eukaryotic membranes
This article has 6 authors:Reviewed by ScreenIT
-
Enantiomers of Chloroquine and Hydroxychloroquine Exhibit Different Activities Against SARS-CoV-2 in vitro , Evidencing S -Hydroxychloroquine as a Potentially Superior Drug for COVID-19
This article has 12 authors:Reviewed by ScreenIT